City View Green Holdings Inc. Stock OTC Markets
Stocks
CVGRF
CA1787182015
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0256 USD | -3.93% |
|
-4.99% | -65.64% |
| Market Cap | 3.09M 2.2M 1.91M 1.79M 1.64M 210M 3.13M 20.96M 8.23M 105M 8.28M 8.1M 349M | P/E 2024 |
-9.02x | P/E 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 3.27M 2.33M 2.02M 1.89M 1.73M 222M 3.31M 22.14M 8.69M 111M 8.74M 8.55M 369M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
84.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.93% | ||
| 1 week | -4.99% | ||
| Current month | -0.96% | ||
| 1 month | -39.97% | ||
| 3 months | +20.66% | ||
| 6 months | -36.39% | ||
| Current year | -65.64% |
| 1 week | 0.03 | 0.03 | |
| 1 month | 0.02 | 0.04 | |
| Current year | 0.01 | 0.18 | |
| 1 year | 0.01 | 0.18 | |
| 3 years | 0 | 0.3 | |
| 5 years | 0 | 0.66 | |
| 10 years | 0 | 1.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roberto Fia
CEO | Chief Executive Officer | 55 | - |
Sung Min Myung
DFI | Director of Finance/CFO | 40 | 04/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Roberto Fia
BRD | Director/Board Member | 55 | 10/11/2014 |
Andrew Peterson
CHM | Chairman | 78 | - |
Steve Naraine
BRD | Director/Board Member | - | 01/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.93% | -4.99% | - | - | 2.2M | ||
| +0.14% | -3.77% | -9.29% | -6.26% | 13.4B | ||
| -0.84% | -3.33% | +4.09% | +6.37% | 5.09B | ||
| +0.85% | -4.72% | -31.73% | -54.46% | 5.04B | ||
| +4.49% | +2.16% | +4.81% | -31.02% | 4.02B | ||
| -4.39% | -3.82% | -3.29% | +3.39% | 3.7B | ||
| +0.84% | -2.92% | -9.10% | -4.42% | 3.66B | ||
| +1.48% | -1.01% | -4.20% | +12.93% | 3.43B | ||
| +3.37% | +2.11% | -11.98% | -21.70% | 2.41B | ||
| +0.23% | -5.28% | -3.72% | +48.27% | 1.85B | ||
| Average | +0.22% | -2.13% | -7.16% | -5.21% | 4.73B | |
| Weighted average by Cap. | +0.48% | -2.40% | -7.98% | -8.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -388K -277K -240K -225K -206K -26.35M -393K -2.63M -1.03M -13.16M -1.04M -1.02M -43.82M | -1.06M -759K -658K -616K -564K -72.26M -1.08M -7.21M -2.83M -36.1M -2.85M -2.79M -120M |
| Net Debt | 68.01K 48.47K 42.06K 39.38K 36.03K 4.62M 68.9K 461K 181K 2.31M 182K 178K 7.68M | 174K 124K 108K 101K 92.13K 11.81M 176K 1.18M 462K 5.9M 465K 455K 19.64M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | $0.0257 | -3.93% | 30,000 |
| 03/08/26 | $0.0267 | +2.89% | 20,000 |
| 31/07/26 | $0.0260 | -4.07% | 20,000 |
- Stock Market
- Stocks
- CVGR Stock
- CVGRF Stock
Select your edition
All financial news and data tailored to specific country editions
















